IT1312568B1 - IMMUNOGENIC PEPTIDES AND THEIR USE. - Google Patents
IMMUNOGENIC PEPTIDES AND THEIR USE.Info
- Publication number
- IT1312568B1 IT1312568B1 IT1999MI001121A ITMI991121A IT1312568B1 IT 1312568 B1 IT1312568 B1 IT 1312568B1 IT 1999MI001121 A IT1999MI001121 A IT 1999MI001121A IT MI991121 A ITMI991121 A IT MI991121A IT 1312568 B1 IT1312568 B1 IT 1312568B1
- Authority
- IT
- Italy
- Prior art keywords
- immunogenic peptides
- immunogenic
- peptides
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI001121A IT1312568B1 (en) | 1999-05-21 | 1999-05-21 | IMMUNOGENIC PEPTIDES AND THEIR USE. |
| EP00935053A EP1179019A2 (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides derived from mage and the use thereof |
| HK02108670.8A HK1047116A1 (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides and the use thereof |
| KR1020017014828A KR20020011418A (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides derived from MAGE and the use thereof |
| IL14660500A IL146605A0 (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides derived from mage and the use thereof |
| CNB008092303A CN1227264C (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides from MAGE and their use |
| PCT/EP2000/004465 WO2000071573A2 (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides derived from mage and the use thereof |
| AU50676/00A AU777474B2 (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides and the use thereof |
| CA002374354A CA2374354A1 (en) | 1999-05-21 | 2000-05-17 | Immunogenic peptides derived from mage and the use thereof |
| JP2000619828A JP2003502026A (en) | 1999-05-21 | 2000-05-17 | MAGE-derived immunogenic peptides and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI001121A IT1312568B1 (en) | 1999-05-21 | 1999-05-21 | IMMUNOGENIC PEPTIDES AND THEIR USE. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI991121A1 ITMI991121A1 (en) | 2000-11-21 |
| IT1312568B1 true IT1312568B1 (en) | 2002-04-22 |
Family
ID=11383013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT1999MI001121A IT1312568B1 (en) | 1999-05-21 | 1999-05-21 | IMMUNOGENIC PEPTIDES AND THEIR USE. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1179019A2 (en) |
| JP (1) | JP2003502026A (en) |
| KR (1) | KR20020011418A (en) |
| CN (1) | CN1227264C (en) |
| AU (1) | AU777474B2 (en) |
| CA (1) | CA2374354A1 (en) |
| HK (1) | HK1047116A1 (en) |
| IL (1) | IL146605A0 (en) |
| IT (1) | IT1312568B1 (en) |
| WO (1) | WO2000071573A2 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235525B1 (en) * | 1991-05-23 | 2001-05-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
| US5662907A (en) * | 1992-08-07 | 1997-09-02 | Cytel Corporation | Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes |
| US5965535A (en) * | 1997-09-12 | 1999-10-12 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
| US6291430B1 (en) * | 1997-09-12 | 2001-09-18 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
| EP1124834B1 (en) * | 1998-10-29 | 2002-11-06 | The Dow Chemical Company | Preparation of titanium(ii) or zirconium(ii) complexes |
-
1999
- 1999-05-21 IT IT1999MI001121A patent/IT1312568B1/en active
-
2000
- 2000-05-17 IL IL14660500A patent/IL146605A0/en unknown
- 2000-05-17 HK HK02108670.8A patent/HK1047116A1/en unknown
- 2000-05-17 JP JP2000619828A patent/JP2003502026A/en active Pending
- 2000-05-17 AU AU50676/00A patent/AU777474B2/en not_active Ceased
- 2000-05-17 KR KR1020017014828A patent/KR20020011418A/en not_active Abandoned
- 2000-05-17 CA CA002374354A patent/CA2374354A1/en not_active Abandoned
- 2000-05-17 CN CNB008092303A patent/CN1227264C/en not_active Expired - Fee Related
- 2000-05-17 WO PCT/EP2000/004465 patent/WO2000071573A2/en not_active Ceased
- 2000-05-17 EP EP00935053A patent/EP1179019A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003502026A (en) | 2003-01-21 |
| IL146605A0 (en) | 2002-07-25 |
| WO2000071573A2 (en) | 2000-11-30 |
| AU777474B2 (en) | 2004-10-21 |
| HK1047116A1 (en) | 2003-02-07 |
| CA2374354A1 (en) | 2000-11-30 |
| CN1360595A (en) | 2002-07-24 |
| AU5067600A (en) | 2000-12-12 |
| WO2000071573A3 (en) | 2001-04-05 |
| KR20020011418A (en) | 2002-02-08 |
| CN1227264C (en) | 2005-11-16 |
| ITMI991121A1 (en) | 2000-11-21 |
| EP1179019A2 (en) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS6040A (en) | Valdekoxib preparations | |
| DK1210113T3 (en) | Combined vaccine preparations | |
| NL1015859A1 (en) | Pharmaceutical preparations. | |
| EP1329217A4 (en) | SOLID PREPARATIONS | |
| BR0017112B1 (en) | Water soluble bag composition and use of the composition. | |
| MXPA02004770A (en) | THERAPEUTIC COMPOSITIONS AND METHODS FOR USE. | |
| NO20013883L (en) | Freeze-dried agent containing paramylon, as well as the preparation and use thereof | |
| MXPA03003283A (en) | IMPROVED ZEOLITES AND MOLECULAR SIZES AND ITS USE. | |
| MXPA03004932A (en) | Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors. | |
| DE60135797D1 (en) | leatherette | |
| FR2791348B1 (en) | POLYPEPTIDE Npt2B | |
| IT1291823B1 (en) | PSEUDO-PEPTIDE COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS | |
| IT1312568B1 (en) | IMMUNOGENIC PEPTIDES AND THEIR USE. | |
| NO20013933D0 (en) | peptides | |
| IT1310419B1 (en) | PIN FOR DENTAL USE. | |
| DE50009295D1 (en) | NETWORK-FREE PREPARATIONS | |
| FR2798017B1 (en) | DEPHASER, AND DEMODULATOR USING THE SAME | |
| IT1317895B1 (en) | PSEUDO-METALLOPROTEIN, THEIR PREPARATION AND THEIR USE. | |
| IT1307020B1 (en) | N-NITRO-DINITRO-ANYLENE N-DENITRATION PROCEDURE IN PHASEOMOGENEOUS. | |
| EP1151100A4 (en) | PEPTIDES DESIGNED TAU-CONOTOXINS | |
| ATA90082000A (en) | SEATING | |
| FI4153U1 (en) | Canopies | |
| ITMI981503A1 (en) | MINIATURE HEMOPROTEINS, THEIR PREPARATION AND THEIR USE | |
| ES1046144Y (en) | PERFECTED UMBRELLA. | |
| ES1044492Y (en) | PARASOL. |